Related Experiment Videos
[Impetigo in children: etiology and response to treatment]
Revista Chilena De Pediatria
|May 1, 1989
Abstract:
Seventy seven cases of impetigo were studied in children. Group A beta hemolyticus Streptococcus was the only bacterial agent isolated from 25 culture samples, Staphylococcus aureus from 6 and both agents from 39 cases. Cultures were negative in 7 children. The clinical response to treatment with penicillin G benzathine, crust removal and skin cleansing was satisfactory in 93.5% of the cases, nonresponders (6.5%) were satisfactory treated oral with cloxacillin.
Insights
This study on childhood impetigo found Group A Streptococcus and Staphylococcus aureus are common causes. Effective treatment with penicillin G benzathine and supportive care achieved high cure rates.
Area of Science:
- Pediatric infectious diseases
- Bacteriology
- Dermatology
Context:
- Impetigo is a common bacterial skin infection in children.
- Understanding causative agents and treatment efficacy is crucial for pediatric care.
Purpose:
- To identify the primary bacterial pathogens responsible for impetigo in a pediatric cohort.
- To evaluate the clinical effectiveness of penicillin G benzathine combined with local wound care for impetigo treatment.
Summary:
- Group A beta-hemolytic Streptococcus and Staphylococcus aureus were identified as the main bacterial agents in 77 pediatric impetigo cases.
- A combination therapy including penicillin G benzathine, crust removal, and skin cleansing resulted in a satisfactory clinical response in 93.5% of cases.
- A small percentage of non-responders were effectively treated with oral cloxacillin.
Impact:
- Provides evidence supporting the efficacy of standard treatment protocols for pediatric impetigo.
- Highlights the prevalence of specific bacterial pathogens, informing antimicrobial stewardship.
- Contributes to the understanding of impetigo management in pediatric populations.